XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Sep. 30, 2023
Mar. 31, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2023
Operating Activities              
Net loss attributable to stockholders $ (9,995,137)   $ (5,608,021) $ (19,069,836) $ (29,064,973) $ (14,239,445)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation expense         121,075 66,436  
Accretion of financing costs   $ 282,624   1,865,154 3,014,414  
Amortization of right-of-use asset         75,788 75,787  
Unrealized loss on investment 19,089   (2,949)   24,586 11,709  
Stock-based compensation   3,369,269   7,691,511 12,322,198 6,078,889 $ 9,757,395
Shares issued for professional services       (448) (1,047) 47,275  
Change in fair value of derivative liability         419,739  
Changes in operating assets and liabilities:              
Inventory         (497,341)  
Grants receivable         (207,266) (276,231)  
Prepaid expenses and deposits         799,596 (837,180)  
Other current assets         (316,351)    
Accounts payable and accrued liabilities   414,071   2,502,865 969,487 (1,653,541) 157,204
Net change in operating lease liability         (90,427) (89,759)  
Net Cash Used in Operating Activities   (4,758,984)   (7,418,700) (12,430,522) (10,816,060) (13,367,980)
Investing Activities              
Other acquisition deposits         (279,878) (6,081,591)  
Acquisition of property, equipment, and water rights         (11,586,857) (3,918,863)  
Acquisition cost reimbursements from government grants         672,404  
Purchase of mining properties         (169,714) (8,007,362)  
Net Cash Used in Investing Activities         (11,364,045) (18,007,816)  
Financing Activities              
Proceeds from issuance of common shares, net of issuance costs         8,857,351  
Proceeds from exercise of share purchase warrants         37,498  
Principal paid on notes payable         (18,600,000)  
Proceeds from notes payable, net of issuance costs         20,287,118  
Proceeds from share purchase agreements, net of issuance costs         25,744,936 3,558,373  
Net Cash Provided by Financing Activities         27,469,552 12,415,724  
Increase (decrease) in Cash         3,674,986 (16,408,152)  
Cash – Beginning of Period   $ 2,320,149   $ 2,320,149 2,320,149 28,989,166 28,989,166
Cash – End of Period $ 5,995,134   $ 12,581,014   $ 5,995,134 $ 12,581,014 $ 2,320,149